Radioactive nuclei for medical applications

• Authors: Jerzy Jastrzębski
• Languages of publication: EN

Abstracts

EN

The radioisotopes used for labeling the diagnostic and therapeutic radiopharmaceuticals are contemporaneously produced using neutrons in reactors and light charged particles from accelerators (cyclotrons). After the presentation of both methods the commercially available cyclotrons are reviewed. Some examples of the most popular medical radioisotopes are given. The new Radiopharmaceuticals Production and Research Centre at the University of Warsaw is presented.

• Publisher: Wydawnictwo Uniwersytetu Marii Curie-Skłodowskiej
• Journal: Annales Universitatis Mariae Curie-Skłodowska, sectio AAA – Physica
• Year: 2011
• Volume: 66
• Pages: 49-70

Dates

published

1 - 1 - 2011

online

14 - 2 - 2012

Contributors

author

Jerzy Jastrzębski

• Heavy Ion Laboratory, University of Warsaw, 02-093 Warszawa, ul. Pasteura 5a, Poland

References

• J.-P. Adloff, A Short History of Polonium and Radium; Chemistry Intern.; 33, 20 (2011).
• M. Krawczyk, Marie Skłodowska-Curie et les applications medicales de ses decouvertes, Conf. 100y commemoration of the MCS Nobel Prize in Chemistry, Sorbonne; Paris, 29 Jan. 2011. ISBN 978-83-7637-192-4.
• M. Skłodowska-Curie, Promieniotwórczość; PWN. Warszawa 1953.
• H. van der Keur, Medical radioisotope production without nuclear reactor; World Info. Service on Energy No 710/711 (2010);
• Handbook of Radiopharmaceuticals; M.J. Welch and C.S. Redvanly edit.; John Wiley publ., England, (2003).
• IAEA-Tecdoc-1340, Manual for reactor produced radioisotopes; Vienna, 2003.
• Fiziczeskij Enciklopediczeskij Slovar; Vol. 5, Moskwa, 1966.
• A.V. Nero, Jr.; A Guidebook to Nuclear Reactors; Univ. of California Press, (1979).
• Nuclear Physics and Reactor Theory; DOE Fund. Hadbook 1019/1-93 Washington, D.C. (1993).
• J. Sura
• IAEA Techn. Rep. Ser. No 465, Cyclotron Produced Radionuclides: Principles and Practice; Vienna, 2008.
• A.P. Wolf, W.B. Jones, Cyclotrons for biomedical radioisotope production; Radiochem. Acta 34, 1 (1983).
• IAEA Techn. Rep. Ser. No 468, Cyclotron Produced Radionuclides: Physical Characteristics and Production Methods; Vienna, 2009.
• F. Haddad, L. Ferrer, A. Guertin, T. Carlier, N. Michel, J. Barbet, J.F. Chatal; ARRONAX; a high-energy and high-intensity cyclotron for nuclear medicine; J. Nucl. Med. Mol. Imaging; 35, 1377 (2008).[Crossref]
• R. Vandenbosch and J.R. Huizenga; Nuclear Fission, Academic Press, (1973).
• European Commission; Preliminary Report on Supply of Radioisotopes for Medical Use and Current Developments in Nuclear Medicine, SANCO/C/HW D(2009).
• R. Mikołajczak, J.L. Parus, Reactor Produced Beta-emitting Nuclides for Nuclear Medicine; World. Journ. Nucl. Med. 4, 184 (2005).
• IAEA Rep. on the Techn. Meet. On "Therapeutic Radiopharmaceuticals"; Vienna, (2009).
• C. Apostolidis, R. Molinet, G. Rasmussen and A. Morgenstern: Production of Ac-225 from Th-229 for Targeted α Therapy; Anal. Chem. 77, 6288 (2005).
• C. Apostolodis, R. Molinet, J. McGinley, K. Abbas, J. Mollenbeck, A. Morgenstern: Cyclotron production of Ac-225 for targeted alpha therapy; Appl. Rad. and Isot.; 62, 383 (2005).
• G. Vaidayanathan, M.R. Zalutsky, Astatine Radiopharmaceuticals: Prospects and Problems, Curr. Radiopharm. 3, 1 (2008).
• J. Jastrzębski, J. Choiński, I. Cydzik, D. Hechner, K. Kilian, P. Napiorkowski, I. Mazur; Radiopharmaceuticals Production and Research Centre at the University of Warsaw, presented at 5th Intern. Conf. on Imaging Techn. in Biomed. Sci., Milos Isl., Sep. 2009.
• J. Choiński, A. Jakubowski, J. Jastrzębski, B. Paprzycki, A. Pietrzak, R. Tańczyk, D. Szczepaniak, A. Trzcińska, J. Chudyka, K. Tworek, W. Zipper, B. Petelenz, B. Wąs, A. Bilewicz, M. Łyczko, 211At production on the Warsaw Cyclotron; 7th Symp. on Targeted Alpha Therapy, Berlin, July 2011.
• L. Królicki and A. Teresińska, Stan medycyny nuklearnej w Polsce, presented at XII Zjazd PTMN, Wrocław, Sep. 2010.

Identifiers

DOI

10.2478/v10246-012-0003-8